Strength
100 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315028520
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
3/18/2026
Active Ingredients
ETRAVIRINEApproval Type
Generic (ANDA)
FDA Application
ANDA215402On Market Since
6/5/2022
Pharmacological Classes
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
P-Glycoprotein Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
TOPIRAMATE 25 MG TABLET
Generic
00904692861•Major Pharmaceuticals
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
29300011505•Unichem Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
29300011510•Unichem Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
29300011516•Unichem Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
47335070713•Sun Pharmaceutical Industries Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
47335070786•Sun Pharmaceutical Industries Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
65862017160•Aurobindo Pharma Limited
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
68084034201•American Health Packaging
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
68382013805•Zydus Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
68382013814•Zydus Pharmaceuticals (USA) Inc.
$0.0257
per EA